Dechend Ralf
und Helios Klinikum Berlin Buch, Charité Campus Buch, Experimental and Clinical Research Center (ECRC), Lindenberger Weg 80, 13125, Berlin, Germany.
MMW Fortschr Med. 2022 Apr;164(Suppl 6):11-17. doi: 10.1007/s15006-022-0959-z.
The clinical picture of coronary artery disease has changed considerably in past years. As a consequence, the medical condition was re-defined in 2019 as "chronic coronary syndrome" (CCS). In view of these developments, the primary aim of the ALTHEA study was to gain current insights into the management of patients with CCS and stable angina in German primary care settings.
ALTHEA is a national, cross-sectional study that used a structured 10-item-questionaire containing single-choice and multiple-choice questions on diagnosis, symptomatic therapy and quality of life of patients with suspected or confirmed CCS and stable angina. Interviewees were primary care practitioners (PCPs) from Germany.
Interviews were conducted between April and September 2021. In total 1,050 PCPs were asked country-wide, aimed at achieving a representative sample. Of the 1,050 PCPs 1,021 replied. The majority of respondents indicated that they would carry out instrument-based diagnostic tests on their own, including a stress electrocardiogram, if CCS was suspected. Regarding treatment goals, the majority of the interviewees gave more relevance to an enhanced quality of life compared to prognostic improvements. In addition, most participants stated that they independently initiate and control symptomatic therapy in patients with suspected CCS and stable angina. Amongst the available antianginal medications, the interviewees showed preferences in terms of efficacy (betablockers), tolerability (ranolazine) and effect on quality of life (ranolazine).
The cross-sectional study shows that PCPs currently serve as relevant guides to cardiologists in the care of patients with suspected CCS and stable angina. PCPs provide support in several areas such as diagnosis and symptomatic therapy, in part intersecting with cardiologists' tasks. Hence the study reveals a close link between primary care and cardiology in the management of patients with CCS.
在过去几年中,冠状动脉疾病的临床表现发生了很大变化。因此,2019年该疾病被重新定义为“慢性冠状动脉综合征”(CCS)。鉴于这些进展,ALTHEA研究的主要目的是深入了解德国基层医疗环境中CCS和稳定型心绞痛患者的管理情况。
ALTHEA是一项全国性横断面研究,使用一份包含10个项目的结构化问卷,其中包括关于疑似或确诊CCS和稳定型心绞痛患者的诊断、症状治疗及生活质量的单项选择题和多项选择题。受访者为来自德国的基层医疗从业者(PCP)。
访谈于2021年4月至9月进行。在全国范围内共询问了1050名PCP,旨在获得具有代表性的样本。1050名PCP中有1021人回复。大多数受访者表示,如果怀疑患有CCS,他们会自行进行基于仪器的诊断测试,包括运动心电图。关于治疗目标,与改善预后相比,大多数受访者更重视提高生活质量。此外,大多数参与者表示,他们会独立启动并控制疑似CCS和稳定型心绞痛患者的症状治疗。在现有的抗心绞痛药物中,受访者在疗效(β受体阻滞剂)、耐受性(雷诺嗪)和对生活质量的影响(雷诺嗪)方面表现出偏好。
这项横断面研究表明,在疑似CCS和稳定型心绞痛患者的护理方面,PCP目前是心脏病专家的重要指导。PCP在诊断和症状治疗等多个领域提供支持,部分与心脏病专家的任务重叠。因此,该研究揭示了在CCS患者管理中基层医疗与心脏病学之间的密切联系。